Additional information
| Use in sports | Not typically used in sports |
|---|---|
| Formula | C5H4N4O |
| Side effects | Rash, Stevens-Johnson syndrome, gastrointestinal disturbance, liver enzyme abnormalities |
| Effects | Lowers serum and urinary uric acid levels |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 100-300 mg daily, may be increased to 600 mg daily in severe cases |
| Half-life | 1 to 2 hours |
| Main action | Reduces uric acid production |
| Substance class | Xanthine oxidase inhibitor |
| Chemical name | 1H-pyrazolo[3,4-d]pyrimidin-4-ol |
| Water Retention | No significant effect |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Trade name | Zyloprim, Aloprim |
| Blood pressure | No significant effect |
| Also known as | Allopurinol |
| Strength | 300 mg |
| Lab Test | Uric acid levels |
| Hepatotoxicity | Rare but possible liver enzyme abnormalities |
| Manufacturer | Cipla |
